New Mexico

The Department of Health Care Medical Assistance Division notified Medicaid Pharmacy Providers that some of the Group and PCNs were incorrect. Here’s the updated list:

Presbyterian

  • PBM Name: Capital RX
  • BIN: 610744
  • PCN: CRXMC
  • Group: PHPCAID

United Healthcare

  • PBM Name: Optum Rx
  • BIN: 610494
  • PCN: 4941
  • Group: ACUNM

Molina

  • PBM Name: CVS Caremark
  • BIN: 004336
  • PCN: MCAIDADV
  • Group: RX51EA

Blue Cross Blue Shield

  • PBM Name: Prime Therapeutics
  • BIN: 011552
  • PCN: SALUD
  • Group: N72100 – N/A

Fee-For-Service

  • PBM Name: Conduent
  • BIN: 610084
  • PCN: DRNMPROD
  • Group: NEWMEXMED

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-07-11T11:13:37-04:00July 11, 2024|New Mexico|

New York

NYRx, the State Medicaid Prescription Drug Program, posted a Pharmacy Prior Authorizations Programs Update. This update is effective August 1, 2024.

Also in New York, the Office of Health Insurance Programs of the State Department of Health has approved the release of the May 2024 Medicaid Update. This update includes a pharmacy reminder that Medicaid providers are required to bill applicable third parties that may be liable for a claim before billing Medicaid. Medicaid is always the payor of last resort and federal regulations require that all other available resources be used before Medicaid considers payment.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2024-07-11T11:12:51-04:00July 11, 2024|New York|

Oregon

The Prescription Drug Affordability Board (PDAB) posted the agenda for its next meeting on July 24. Please register in advance of the meeting.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-07-11T11:11:43-04:00July 11, 2024|Oregon|

Pennsylvania

HB 1993, a PBM reform bill has advanced in the Senate, signaling that there is agreement among the General Assembly and the Governor’s office to pass it prior to summer recess. This week, after intense lobbying by pharmacy, the Senate adopted an amendment to the bill that not only strengthened the PBM provisions from a previous version, but also expanded pharmacy vaccine authority for children, to better align with PREP Act. Specifically, it will allow pharmacists and interns to provide all ACIP-approved vaccines to children aged 8 years and older. It also will authorize Pharmacy Technicians with national certification and vaccine training to immunize children aged thirteen years and older for flu and Covid, effective upon passage; while non-certified technicians will be eligible once the proposed Technician Regulations are approved, and they have registered and received immunization training. NACDS and the Pennsylvania Association of Chain Drug Stores have been working on both issues since the beginning of the Legislative Session in partnership with the Pennsylvania Pharmacists Association and other stakeholders. The bill passed the full Senate and needs a concurrence vote in the House.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-07-11T11:11:14-04:00July 11, 2024|Pennsylvania|

Texas

Acting on behalf of Gov. Greg Abbott (R) while he is out of the country on a trade mission, Lt. Gov. Dan Patrick (R) declared a Disaster Declaration for 121 counties impacted by Hurricane Beryl. The Board of Pharmacy’s Executive Director/Secretary Daniel R. Carroll, PharmD, RPh, has again authorized pharmacists in Texas to dispense up to a 30-day supply of medication (other than a Schedule II controlled substance) for patients affected in the counties of the disaster area. Board rule 291.34(b)(8)(E) outlines the procedures for dispensing medication in emergency situations.

Also in Texas, the next hybrid meeting of the Texas Pharmaceutical Initiative Board will be at 1:00 pm on July 16.

Also in Texas, the Health and Human Services Commission (HHSC) Vendor Drug Program (VDP) will perform the semi-annual update of the Medicaid preferred drug list on July 25, based on the recommendations made at two meetings of the Texas Drug Utilization Review early this year.

Finally in Texas, The Texas Drug Utilization Review Board agenda for July 26 is now available. Refer to the Texas Drug Utilization Review Board Handbook for instructions on submitting written materials to the board before the meeting and public testimony on the day of the meeting. People providing written or public testimony must complete the appropriate testimony form and the Public Comment Registration form linked on the agenda.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-07-11T11:10:49-04:00July 11, 2024|Texas|

Washington

The Pharmacy Quality Assurance Commission (commission) is soliciting public comments on its draft rule language for Mobile Opioid Treatment Program (OTP) Units. The rules workshop will be held at the August 22 Business Meeting. The draft rule language proposes to amend WAC 246-945-060 and WAC 246-945-250 to modify registration and facility requirements pertaining to mobile OTP units and the other controlled substance registration. The Proposed Mobile Opioid Treatment Program Unit Rule Language may change in response to future feedback from the commission and the public. Written comments may be submitted to Haleigh Mauldin, Program Consultant, at PharmacyRules@doh.wa.gov until midnight on August 8. Oral comments may be provided at the August rules workshop.

Also in Washington, Apple Health’s new pharmacy point-of-sale system is a few weeks post go-live and the Health Care Authority’s pharmacy team has scheduled several listening sessions to meet with pharmacy billers to gather feedback regarding experiences with claims and prior authorizations

Finally in Washington, the third quarter Washington preferred drug list (PDL) has been posted to the website. The state’s PDL shows which drugs are preferred and which are non-preferred for Uniform Medical Plan and the Department of Labor and Industries.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-07-11T11:10:14-04:00July 11, 2024|Washington|

Alaska

The Board of Pharmacy reminded licensees that both pharmacy and facility licensing renewal applications are due by 11:59 pm on June 30 or the license will expire. There is no grace period. Here are the links to the Alaska Board of Pharmacy applications and forms:

If you have not registered your corporate entity in Alaska yet, you can find information on how to register your entity at Corporations, Division of Corporations, Business and Professional Licensing (alaska.gov).

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-06-27T11:05:22-04:00June 27, 2024|Alaska|

California

The Department of Health Care Servies posted the following weekly notice on the Medi-Cal Rx Web Portal: Medi-Cal Rx Weekly Wrap-up for June 14-20.

Also in California, as part of Gov. Gavin Newsom’s (D) Master Plan for Tracking the Fentanyl and Opioid Crises, California will make its own private label branded over the counter (OTC) naloxone hydrochloride (HCL) nasal spray (CalRx®). It will be available for free to eligible organizations through the California Department of Health Care Services (DHCS) Naloxone Distribution Project (NDP) or for sale for $24 per twin-pack. The state is also working on an option for individuals to buy CalRx OTC naloxone nasal spray directly.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-06-27T11:04:53-04:00June 27, 2024|California|

© National Association of Chain Drug Stores
All Rights Reserved | Privacy & Disclaimer

Go to Top